DGLY, NASDAQ #Listing Compliance Regained Digital Ally Regains Compliance with Nasdaq Minimum Bid Price Requirement February 23, 2023 11:33 EST LENEXA, KS., Feb. 23, 2023 (GLOBE NEWSWIRE) — Digital Ally, Inc. (the “Company”)(Nasdaq: DGLY), today announced that it received a notification letter (the “Notification Letter on Compliance”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on February 23, 2023, indicating that the Company has regained No Comments
BSGM, NASDAQ #Listing Compliance Regained #Trending News BioSig Regains Compliance With All Nasdaq Listing Standards February 22, 2023 07:30 EST Westport, CT, Feb. 22, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, announced today that it has received written notice from the Nasdaq No Comments
LEGN, NASDAQ #Listing Compliance Regained #Trending News Legend Biotech Regains Compliance with NASDAQ Listing Rule 5250(c)(2) February 21, 2023 08:30 EST SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (“Legend Biotech” or the “Company”) (NASDAQ: LEGN), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, announced that it received notice from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) on February 17, 2023 indicating that the No Comments
LMDX, NASDAQ #Listing Compliance Regained #Trending News LumiraDx Regains Compliance with Nasdaq Continued Listing Requirements February 17, 2023 16:15 EST LONDON, Feb. 17, 2023 (GLOBE NEWSWIRE) — LumiraDx Limited (Nasdaq: LMDX) (the “Company”) today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1). On January 27, 2023, Nasdaq notified No Comments
LMNL, NASDAQ #Listing Compliance Regained #Trending News Liminal BioSciences Regains Compliance with NASDAQ Minimum Bid Price Requirement February 15, 2023 16:05 EST LAVAL, QC, Feb. 15, 2023 /PRNewswire/ — Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”), announced that it has received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq’s minimum bid price for continued listing on the Nasdaq Capital No Comments
EDBL, EDBLW, NASDAQ #Listing Compliance Regained #Trending News Edible Garden Regains Compliance with Nasdaq Continued Listing Requirements February 15, 2023 08:30 EST BELVIDERE, NJ, Feb. 15, 2023 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced that it received notice from Nasdaq on February 10, 2023 indicating that No Comments
HUGE, NASDAQ #Listing Compliance Regained #Trending News FSD Pharma Regains Compliance with NASDAQ Continued Listing Requirements February 15, 2023 07:30 EST TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, today announced that the company has received confirmation from The No Comments
HILS, NASDAQ #Listing Compliance Regained #Trending News Hillstream BioPharma Regains Compliance with Nasdaq Listing Minimum Bid Price Rule February 15, 2023 07:11 EST Company Hosted its R&D Day to Discuss Product and Pipeline Goals Across 4 Pipeline Candidates and its Quatramer™ Tumor-Targeting Platform; Multiple inflection points over the next 12-18 Months Company’s Novel Emerging Anti-Cancer Mechanism, Ferroptosis, Addresses Potential Key Target Oncology Markets Projected to reach $11 Billion in 2028 Signs Exclusive Option Agreement No Comments
NASDAQ, WPRT #Listing Compliance Regained Westport Regains Compliance with Nasdaq Minimum Bid Requirement February 15, 2023 06:30 EST VANCOUVER, British Columbia, Feb. 15, 2023 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport” or the “Company”) (TSX: WPRT / Nasdaq: WPRT), a global leader in low-emissions alternative fuel transportation technologies, announced today that it has received a Bid Price Compliance Letter from the Nasdaq Listing Qualifications Staff of No Comments
KTRA, NASDAQ #Cancer #Corporate Presentation #Financial Data #Listing Compliance Regained Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update February 14, 2023 17:00 EST SAN DIEGO, Feb. 14, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (NASDAQ: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal second quarter ended December 31, 2022 and provided a corporate update. RECENT CORPORATE No Comments
Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock 02/23/2023
Columbia Banking System Set to Join S&P MidCap 400; Verra Mobility to Join S&P SmallCap 600 02/23/2023
NIO’s F4 plant will be located in Chuzhou to produce models for Firefly sub-brand, report says 02/20/2023